Claim and version register
The workflow defines what is monitored, who reviews it and who is allowed to respond. Sensitive matters move to a private route.
Pharma & medtech / Reputation
Let trust rest on something real.
Keep information accurate, listen to genuine feedback and agree how concerns move from a public comment to a responsible owner.
What the work can include
Reputation deliverables for pharma & medtech
Medical and regulatory approval workflow
Requests for genuine feedback are neutral. Review purchases, incentives and selective positive-only solicitation are not part of the service.
Public-information correction process
Accurate information, verified evidence and explicit permissions support public trust. Any unsupported claim is held for review.
Inquiry and complaint escalation
Escalation categories route relevant issues to operations or the authorised professional. The agency does not resolve matters beyond its remit.
Document ownership standards
Reporting summarises recurring feedback themes and action status without exposing sensitive customer details. Response counts are not rating promises.
Evidence-source audit trail
The maintenance record tracks approvals, information changes, corrections and next steps so responsibility remains clear.
Product, medical, regulatory and legal review is required before publication. This is not a direct-to-consumer prescription-promotion package. No unsupported efficacy or safety claims.
Built for pharma & medtech
Know the rules.
Show the proof.
Industry expertise is the part a generic agency or an AI tool cannot fake. Every claim we help publish is checked against these first.
Rules we work within
- Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954
- Uniform Code for Pharmaceutical Marketing Practices (UCPMP), 2024
- Drugs and Cosmetics Rules on promoting prescription medicines to the public
- ASCI guidelines on health claims
Pointers for review, not legal advice. Specialist sign-off is arranged where your claims need it.
What a trustworthy pharma & medtech brand shows
- Approved, referenced product information
- Clear manufacturing and quality credentials
- Pharmacovigilance / adverse-event contact
- Separate HCP information
Use this to judge any provider—including us.
What reaches your team
A useful handover.
Not a mystery report.
- The approved work plan and final deliverable folder
- Access and ownership record for agreed accounts
- Approval log and factual sources provided by your team
- Measurement definitions and the limits of available data
- Priority recommendations for the next phase
Free · 2 minutes · no email
How healthy is your
pharma & medtech brand?
Answer eight quick questions written for pharma & medtech businesses. Get a score, your weakest area and the first three things to fix.
- Sample questionEvery product claim links to an approved source and a named reviewer.
- Sample questionHealthcare professionals and the public reach different, appropriate information.
- Sample questionCorporate, product and therapy-area brands follow one clear hierarchy.
The customer experience
Evidence-to-information system.
These are the stages we design around. Open the interactive map to inspect the work and handoff.
- 01
Define
Confirm audience, intended use and permitted communication scope.
Approved communication brief - 02
Evidence
Map claims to current approved supporting information.
Evidence and version register - 03
Explain
Design clear materials for the approved audience.
Reviewed product or capability material - 04
Connect
Route appropriate business enquiries to the relevant team.
B2B enquiry and document handoff
What is included in reputation for pharma & medtech?
Typical deliverables are claim and version register, medical and regulatory approval workflow, public-information correction process, inquiry and complaint escalation. The exact quantities, revisions and handover are fixed in the statement of work before work begins.
How much does reputation cost?
Work usually starts with Diagnose the problem (from ₹40,000), which confirms whether reputation is the real priority. The closest engagement, Operate & improve, has a proposed starting fee of ₹1,20,000 per month. A final quotation follows the scope agreement.
How do you measure reputation?
Against measures agreed up front, such as approved material coverage, review-cycle turnaround, qualified b2b enquiries. Activity, valid enquiries and client-recorded outcomes are reported separately, and missing attribution is documented rather than estimated.
What do you need from us?
A named reviewer, accurate business information, authorised images and evidence, access to the relevant accounts and an operational contact who owns the next customer action.
Can pharma companies advertise medicines on their website?
Prescription medicines should not be promoted to the public, and certain disease claims are prohibited outright. Corporate information, capabilities and approved product information for professionals are possible with medical and regulatory review.
What is UCPMP 2024?
The Uniform Code for Pharmaceutical Marketing Practices sets expectations for how pharmaceutical companies promote products and engage healthcare professionals, including evidence-based claims and restrictions on gifts and hospitality.
The next considered step
Evidence before expression.
Let’s start there.
Tell us about the business, the gap and the work you need. Start with a useful brief—not a bigger package.